Related Experiment Video
Updated: Jun 4, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
The effect of combining antibiotics on resistance: A systematic review and meta-analysis
Berit Siedentop1,2, Viacheslav N Kachalov2,3, Christopher Witzany1
1Institute of Integrative Biology, Department of Environmental Systems Science, ETH Zürich, Zurich, Switzerland.
Background:
Under which conditions antibiotic combination therapy decelerates rather than accelerates resistance evolution is not well understood. We examined the effect of combining antibiotics on within-patient resistance development across various bacterial pathogens and antibiotics.
Methods:
We searched CENTRAL, EMBASE, and PubMed for (quasi)-randomised controlled trials (RCTs) published from database inception to 24 November 2022. Trials comparing antibiotic treatments with different numbers of antibiotics were included. Patients were considered to have acquired resistance if, at the follow-up culture, a resistant bacterium (as defined by the study authors) was detected that had not been present in the baseline culture. We combined results using a random effects model and performed meta-regression and stratified analyses. The trials' risk of bias was assessed with the Cochrane tool.
Results:
42 trials were eligible and 29, including 5054 patients, qualified for statistical analysis. In most trials, resistance development was not the primary outcome and studies lacked power. The combined odds ratio for the acquisition of resistance comparing the group with the higher number of antibiotics with the comparison group was 1.23 (95% CI 0.68-2.25), with substantial between-study heterogeneity (I2=77%). We identified tentative evidence for potential beneficial or detrimental effects of antibiotic combination therapy for specific pathogens or medical conditions.
Conclusions:
The evidence for combining a higher number of antibiotics compared to fewer from RCTs is scarce and overall compatible with both benefit or harm. Trials powered to detect differences in resistance development or well-designed observational studies are required to clarify the impact of combination therapy on resistance.
Funding:
Support from the Swiss National Science Foundation (grant 310030B_176401 (SB, BS, CW), grant 32FP30-174281 (ME), grant 324730_207957 (RDK)) and from the National Institute of Allergy and Infectious Diseases (NIAID, cooperative agreement AI069924 (ME)) is gratefully acknowledged.
Insights
Antibiotic combination therapy
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Understanding antibiotic resistance evolution is crucial.
- The impact of combination therapy on resistance is not fully understood.
- This study investigates how combining antibiotics affects resistance development within patients.
Purpose of the Study:
- To analyze the effect of antibiotic combination therapy on the development of bacterial resistance.
- To explore conditions under which combination therapy might decelerate resistance.
- To assess resistance development across diverse bacterial pathogens and antibiotic regimens.
Main Methods:
- Systematic review and meta-analysis of (quasi)-randomised controlled trials (RCTs).
- Searched CENTRAL, EMBASE, and PubMed databases up to November 24, 2022.
- Included trials comparing different numbers of antibiotics; assessed resistance acquisition from baseline to follow-up cultures.
Main Results:
- 42 trials were identified, with 29 (5054 patients) included in the analysis.
- The pooled odds ratio for resistance acquisition with more antibiotics was 1.23 (95% CI 0.68-2.25), indicating substantial heterogeneity (I²=77%).
- Tentative evidence suggests potential benefits or harms of combination therapy depending on the pathogen or condition.
Conclusions:
- Evidence from RCTs on combination therapy's impact on resistance is limited and inconclusive.
- Current data is compatible with both beneficial and detrimental effects.
- Further powered trials and well-designed observational studies are needed to clarify combination therapy's role in resistance development.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...